Obeticholic acid (Ocaliva) for primary biliary cholangitis.
D002635:Chenodeoxycholic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002761:Cholangitis / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008105:Liver Cirrhosis, Biliary / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists; D016896:Treatment Outcome; D000099150:Receptor, Farnesoid X-Activated
D002635:Chenodeoxycholic Acid; D005765:Gastrointestinal Agents; D018160:Receptors, Cytoplasmic and Nuclear; D000099150:Receptor, Farnesoid X-Activated; C464660:obeticholic acid